In response to the increasingly problematic emergence of antibiotic resistance, novel 15 strategies for combating pathogenic bacteria are being investigated. Targeting the agr 16 quorum sensing system, which regulates expression of virulence in Staphylococcus 17 aureus, is one potentially useful approach for combating drug-resistant pathogens that 18 has not yet been fully explored. A previously published study of a fragment screen 19 resulted in the identification of five compound fragments that interact with the DNA-20 binding domain of the response regulator AgrA from S. aureus. We have analyzed the 21 ability of these compounds to affect agr-mediated virulence gene expression in S. 22 aureus cells. Three of the compounds demonstrated the ability to reduce agr-driven 23 2 transcription of at the P2 and P3 promoters of the agr operon and increase biofilm 24 formation, and two of these compounds also showed the ability to reduce levels of 25 secreted toxins. The finding that the compounds tested were able to reduce agr activity 26 suggests that they could be useful tools for probing the effects of agr inhibition.
Introduction
Treatment with inhibitors results in decreased production of exoproteins, 163 reduced hemolytic activity, and altered levels of the spa and hla transcripts 164 The agr system regulates virulence in part by increasing the expression of exoproteins 165 such as hemolytic toxins 31 . Inhibition of AgrA activity would therefore be expected to 166 decrease exoprotein production and lead to decreased hemolytic activity. The presence To quantify the differences in levels of secreted proteins upon treatment with 175 compounds, total protein levels in the culture media were measured using a Bradford resultant differences in AgrB, AgrD, and the N-terminal domain of AgrC allow for the 207 production (in the case of AgrB and AgrD) and recognition (in the case of AgrC) of 208 different autoinducing peptides. Based on these differences, S. aureus strains are 209 classified as one of four agr types, numbered I-IV 34, 35 . In contrast to agrB-C, the 210 sequence of agrA is highly conserved within S. aureus, and therefore inhibition of AgrA 211 would be expected to affect strains of all agr types. The USA300 LAC strain belongs to 212 group I. We examined exoprotein levels in type II, III, and IV strains. Treatment with 213 compounds 1 and 2 resulted in decreased production of exoproteins in N315 (agr type 214 II), MW2 (agr type III), and MN EV (agr type IV) strains ( Fig. 5 ). These data are 215 consistent with the proposed mechanism whereby the inhibitors are functioning primarily 216 through inhibition of AgrA.
218
Compounds interact with AgrA with sub-millimolar affinity 219 Binding of the compounds to AgrA C was previously demonstrated by NMR 220 WATERGATE W5 LOGSY and chemical shift perturbation analyses 27 , however, binding 221 affinities were not directly determined. Isothermal titration calorimetry (ITC) was used to 222 measure the affinity of compounds 1-3 for AgrA C . Isotherms were easily fitted to one-223 binding-site models. Fitting of the isotherms was improved by fixing the stoichiometry to 224 N=1. Fitting of the isotherm generated by compound 1 resulted in a measured ∆H of -225 1154 ± 487.0 cal mol -1 , ∆S of 23.4 cal mol -1 deg -1 , and a K d of 485 ± 39.3 μM ( Fig. 6a ).
226
Fitting of the isotherm generated by compound 2 yielded a measured ∆H of -423.4 ± 227 25.19 cal mol -1 , ∆S of 14.0 cal mol -1 deg -1 , and a K d of 417 ± 62.9 μM ( Fig. 6b ). Fitting of 228 the isotherm generated by compound 3 yielded a ∆H of -340.0 ± 35.53 cal mol -1 , ∆S of 17.0 cal mol -1 deg -1 , and a K d of 110 ± 45.6 μM (Fig. 6c ). The relatively large errors 230 associated with the fitting of these parameters can be attributed to difficulties in 231 analyzing low-affinity interactions. Inhibition of virulence has been proposed as a strategy for combating bacterial 236 infections because it exploits previously unexplored targets for inhibition and also has 237 the potential to limit selection for resistance. S. aureus is one pathogen for which 238 virulence inhibition is especially appealing as it produces an extensive array of harmful 239 virulence factors 36 and has a history of antibiotic resistance that dates back to the initial 240 introduction of penicillin 37 . Within S. aureus, the agr quorum sensing system has been and regulation (by activating the quorum sensing mechanism), AgrA has become a target of interest for inhibiting virulence 38, 39 . Our previous fragment screen against the 253 AgrA DNA-binding domain identified five compounds with the potential to act as 254 inhibitors of AgrA 27 . While these compounds were conclusively shown to interact with 255 the LytTR domain of AgrA, they were unproven in their abilities to inhibit agr activity in 256 S. aureus cells.
258
AgrA functions as a transcription factor, and thus the immediate effect of inhibiting AgrA 259 would be to alter the levels of AgrA-regulated transcripts. The presented studies 260 demonstrate that compounds 1-4 significantly reduced the expression of GFP driven by 261 the P3 promoter, and compounds 1-3 reduced levels of transcripts of agrA, RNAIII, 262 psmα, and psmβ, strongly suggesting that the compounds are acting to interfere with 263 AgrA-regulated transcription. However, while the reduction in transcript levels were 264 significant, they were not comparable to levels seen in the ∆agr strain, which were 265 below the threshold of detection under the tested conditions. Optimization of the 266 compounds will therefore be required to achieve complete inhibition of AgrA. interpretation that the compounds were acting by inhibiting transcription at both the P2 286 and P3 promoters. By reducing both the autoregulatory and virulence factor production 287 functions of AgrA, the potency of virulence inhibition could potentially be enhanced.
288
Together, these results suggest that the compounds inhibit virulence gene activation in 289 S. aureus cells in a manner that is consistent with inhibition of the agr system.
291
The compounds examined in this study inhibited several different aspects of agr-292 mediated virulence factor activation, suggesting that they could serve as useful tools for 293 experimental validation of the strategy of targeting the agr system to combat S. aureus 294 infections. Pressing questions regarding the strategy of targeting the agr system to 295 combat S. aureus infections remain unanswered. One of the most problematic issues is 296 the promotion of biofilm formation that is associated with a reduction in agr activity. deficiency has been associated with types of infections for which biofilm formation is 299 especially prevalent 47 . It is possible that the therapeutic efficacy of agr inhibition would 300 depend on the type of infection being treated. Furthermore, the nature of the agr 301 quorum sensing system suggests that the activation of virulence gene expression must 302 be precisely timed in order to be effective. In fact, specifically timed transient inhibition 303 has been shown to attenuate model infections 11 . In light of these timing requirements, it 304 is likely that inhibition at a point either too late or too early during an infection may 305 reduce or eliminate the efficacy of agr inhibition. Discovering the ideal timing of 306 virulence factor inhibition is important for analyzing the effectiveness of the strategy.
Unless otherwise stated, the S. aureus strains used in this study (Table 2) 
